Shop
Showing 1–30 of 429 results
-
-
-
VentureABION BIO
-
-
VentureAbTis – Dong-A ST
AbTis is a leading ADC Biotech Company with the world’s best linker platform technology4. They have developed the 3rd generation of ADC linker technology, AbClick®, which utilizes a cyclic peptide that site-selectively conjugates drugs to natural antibodies without antibody modification. It also controls the number of payloads conjugated to the linker for high yield of conjugation and simple process of purification. Therefore, AbClick® leads cost-effective ADC production with a high therapeutic index.
-
SMEAccessBio Korea
-
VentureAceBiome
AceBiome, a dietary supplements company supplying probiotics products based on microbiome research, spun out of Bioneer Corporation in 2017 and was founded as a subsidiary of Bioneer.
Lactobacillus gasser BNR17′, researched and developed for about twenty years by the researchers of Bioneer and AceBiome, is the first probiotic strain approved by MFDS (Korea FDA) as a functional ingredient to help reduce body fat, and is currently a globally patented probiotic for weight control and diabetes.
Centered around BNR17′ probiotic products that ameliorate overweight and obesity, AceBiome is a fast-growing, global company that seeks to improve human health and quality of life. -
-
-
VentureAimedBio
AIMEDBIO specializes in the clinical development of brain diseases. AIMEDBIO uses its brain-oriented multi-disciplinary platform, consisting of largely five parts – big data, antibody-drug conjugate, blood-brain barrier penetration, brain immune modulation and patient-derived model (PDC/PDX), along the development process of therapeutics for brain diseases.
-
-
-
SMEALTEOGEN Inc.
ALTEOGEN Inc. is a leading bio company whose portfolio includes next-generation biobetters, biosimilars, and proprietary biologics. They are focusing on three cutting-edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate (ADC), and antibody biosimilars with high complexity.
-
-
IngredientAmicogen
Amicogen has equipped with a strategic business structure in 3 business divisions, ‘Enzyme · bio pharmaceuticals’, ‘health care’ and ‘bio process/ CDMO by combining sustainable enzyme technology and its applied technology.
-
-
VentureAnterogen Co., Ltd.
Anterogen Co., Ltd. is a company that focuses on the development of regenerative medicine and cell therapy products. They are committed to the research and development of new drugs for unmet medical needs.
-
-
-
VentureAPITBIO
APITBIO has monoclonal antibody pipelines, bispecific antibody pipelines, and a CAR-T pipeline under co-development.
-
VentureAprilBio
AprilBio is a company that is developing innovative drugs based on antibody fragment-based source technology.
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
-
VentureAptaBio
-
VentureAptamer Sciences Inc.
Aptamer Sciences Inc is a company that focuses on the research and experimental development on natural sciences and engineering.
-
VentureAPURES
APURES is a company that focuses on the development of gene therapy drugs. They have been transforming from a company that produced experimental pigs to a company that develops gene therapy drugs. They have also been recognized for their work in the field of cell-based therapies.
-
-
-
-
